Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China
· Delayed Price · Currency is CNY 4.320
+0.030 (0.70%)
At close: Mar 10, 2026
SHE:300194 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 982.87 | 846.31 | 991.84 | 688.53 | 981.13 | 853.39 | Upgrade
|
| Trading Asset Securities | 80.01 | 30 | 5.05 | 15.21 | 20.86 | 75.67 | Upgrade
|
| Cash & Short-Term Investments | 1,063 | 876.32 | 996.89 | 703.74 | 1,002 | 929.05 | Upgrade
|
| Cash Growth | 9.68% | -12.10% | 41.66% | -29.77% | 7.85% | 7.83% | Upgrade
|
| Accounts Receivable | 243.4 | 255.39 | 359.39 | 433.24 | 393.02 | 370.1 | Upgrade
|
| Other Receivables | 6.92 | 31.31 | 23.8 | 18.92 | 19.66 | 17.89 | Upgrade
|
| Receivables | 250.32 | 286.71 | 383.19 | 452.16 | 412.68 | 387.98 | Upgrade
|
| Inventory | 680.99 | 850.97 | 707.8 | 719.75 | 631.92 | 590.17 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.34 | Upgrade
|
| Other Current Assets | 63.01 | 51.7 | 38.36 | 51.42 | 38.6 | 41.76 | Upgrade
|
| Total Current Assets | 2,057 | 2,066 | 2,126 | 1,927 | 2,085 | 1,949 | Upgrade
|
| Property, Plant & Equipment | 1,706 | 1,767 | 1,736 | 1,696 | 1,446 | 1,222 | Upgrade
|
| Long-Term Investments | 1,264 | 1,216 | 1,183 | 1,072 | 752.43 | 699.42 | Upgrade
|
| Goodwill | 261.18 | 261.18 | 261.18 | 485.69 | 508.66 | 709.72 | Upgrade
|
| Other Intangible Assets | 426.17 | 441.2 | 401.71 | 383.81 | 382.37 | 1,015 | Upgrade
|
| Long-Term Deferred Tax Assets | 70.15 | 60.54 | 65.81 | 101.86 | 49.15 | 40.16 | Upgrade
|
| Long-Term Deferred Charges | 111.35 | 105.37 | 138.52 | 176.2 | 170.25 | 135.89 | Upgrade
|
| Other Long-Term Assets | 71.44 | 61.6 | 63.37 | 35.35 | 312.58 | 201.07 | Upgrade
|
| Total Assets | 5,967 | 5,979 | 5,976 | 5,878 | 5,706 | 5,973 | Upgrade
|
| Accounts Payable | 283.4 | 436.39 | 379.48 | 385.07 | 289.77 | 216.04 | Upgrade
|
| Accrued Expenses | 24.14 | 116.73 | 225.43 | 253.93 | 232.76 | 225.46 | Upgrade
|
| Short-Term Debt | 459.77 | 333.32 | 349.11 | 406.34 | 642.15 | 477.5 | Upgrade
|
| Current Portion of Long-Term Debt | 15.01 | 177.32 | 54.06 | 2.51 | - | - | Upgrade
|
| Current Portion of Leases | - | 1.11 | 0.98 | 0.58 | - | 19.91 | Upgrade
|
| Current Income Taxes Payable | 25.94 | 4.46 | 15.52 | 6.62 | 9 | 12.46 | Upgrade
|
| Current Unearned Revenue | 26.3 | 54.09 | 51.25 | 61.96 | 57.15 | 56.21 | Upgrade
|
| Other Current Liabilities | 109.13 | 103.58 | 119.22 | 170.04 | 57.66 | 53.95 | Upgrade
|
| Total Current Liabilities | 943.69 | 1,227 | 1,195 | 1,287 | 1,288 | 1,062 | Upgrade
|
| Long-Term Debt | 420.7 | 193.54 | 487.14 | 303.7 | 263.88 | 124.21 | Upgrade
|
| Long-Term Leases | 0.08 | 0.49 | 1.57 | 1.06 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 101.38 | 109.91 | 92.36 | 98.06 | 75.03 | 53.09 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 47.31 | 49.5 | 51.09 | 64.35 | 35.92 | 31.64 | Upgrade
|
| Other Long-Term Liabilities | 0.01 | 0.01 | 0.01 | 177.27 | 177.27 | 147.25 | Upgrade
|
| Total Liabilities | 1,513 | 1,580 | 1,827 | 1,932 | 1,841 | 1,418 | Upgrade
|
| Common Stock | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | Upgrade
|
| Additional Paid-In Capital | 2,237 | 2,237 | 2,237 | 2,227 | 2,227 | 2,231 | Upgrade
|
| Retained Earnings | 1,035 | 952.26 | 731.91 | 559.53 | 354.92 | 711.32 | Upgrade
|
| Comprehensive Income & Other | -9.75 | 16.74 | -13.98 | -31.58 | -37.96 | -31.74 | Upgrade
|
| Total Common Equity | 4,452 | 4,396 | 4,145 | 3,945 | 3,734 | 4,100 | Upgrade
|
| Minority Interest | 1.86 | 2.25 | 3.92 | 1.38 | 131.75 | 454.87 | Upgrade
|
| Shareholders' Equity | 4,454 | 4,398 | 4,149 | 3,946 | 3,866 | 4,555 | Upgrade
|
| Total Liabilities & Equity | 5,967 | 5,979 | 5,976 | 5,878 | 5,706 | 5,973 | Upgrade
|
| Total Debt | 895.57 | 705.78 | 892.86 | 714.2 | 906.03 | 621.62 | Upgrade
|
| Net Cash (Debt) | 167.31 | 170.54 | 104.03 | -10.45 | 95.96 | 307.43 | Upgrade
|
| Net Cash Growth | -35.11% | 63.93% | - | - | -68.79% | -58.79% | Upgrade
|
| Net Cash Per Share | 0.15 | 0.15 | 0.09 | -0.01 | 0.08 | 0.26 | Upgrade
|
| Filing Date Shares Outstanding | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | Upgrade
|
| Total Common Shares Outstanding | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | 1,190 | Upgrade
|
| Working Capital | 1,113 | 838.7 | 931.19 | 640.01 | 796.7 | 887.77 | Upgrade
|
| Book Value Per Share | 3.74 | 3.69 | 3.48 | 3.32 | 3.14 | 3.45 | Upgrade
|
| Tangible Book Value | 3,765 | 3,693 | 3,482 | 3,076 | 2,843 | 2,376 | Upgrade
|
| Tangible Book Value Per Share | 3.16 | 3.10 | 2.93 | 2.59 | 2.39 | 2.00 | Upgrade
|
| Buildings | - | 1,246 | 1,191 | 875.88 | 871.16 | 724.77 | Upgrade
|
| Machinery | - | 1,765 | 1,615 | 1,347 | 1,225 | 1,072 | Upgrade
|
| Construction In Progress | - | 114.23 | 155.84 | 695.25 | 441.2 | 427.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.